Efficacy and safety of an innovative formulation of benzalkonium chloride-free latanoprost for the treatment of open-angle glaucoma

Estudio clínico

3374 3378 3379 3376 3377

Palabras claves:

BAK-free, glaucoma, latanoprost, nanoemulsion, superficieocular, toxicidad

Estudios relacionados

Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day forcataract postsurgical inflammation treatment:noninferiority trial

Triple-fixed Combination of Dorzolamide/Timolol/Brimonidine: Efficacy Study in Bolivian Population

Eficacia y tolerabilidad de una novedosa formulación de latanoprost libre de cloruro de benzalconio para el tratamiento de pacientes con glaucoma primario de ángulo abierto

A Comparative Study of Difluprednate 0.05% Nanoemulsion Vs Prednisolone Acetate 1% + Phenylephrine 0.12% Suspension on Postoperative Inflammation Treatment Following Cataract Surgery

Efficacy and Tolerability of a New Latanoprost 0.005%BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

(2018) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles